对于晚年抑郁症的结构化GP-患者-老年精神病学家模型中的联合咨询:一个集群RCT
Lars Christian Kvalbein-Olsen1, Eivind Aakhus2, Ole Rikard Haavet3
1Department of General Practice, Faculty of Medicine, University of Oslo, Oslo, Norway. l.c.kvalbein-olsen@medisin.uio.no.
BMC primary care
|September 30, 2025
概括
这项研究评估了患有抑郁症的老年人协作护理模式,发现与标准护理相比没有统计学上显著的好处. 招聘挑战影响了参与和检测潜在积极结果的能力.
科学领域:
- 老年精神病学是一门精神病学专业.
- 主要护理医学 医疗保健
- 临床心理学 临床心理学
背景情况:
- 患有抑郁症的老年人往往面临有限的初级保健资源和获得专门的老年精神病治疗的机会.
- 这项研究解决了在一般诊所设置中,需要有效的模型来管理老年人群中的抑郁症.
研究的目的:
- 评估全科医生和老年精神病学家之间的结构化协作模式在治疗65岁及以上成人抑郁症方面的有效性.
- 将这种协作干预与标准后续护理进行比较.
主要方法:
- 进行了一项集群随机对照试验,65岁以上的患者经历中度抑郁症状 (患者健康问卷-9 [PHQ-9] 分数为10-19).
- 该干预涉及全科医生,患者和老年精神病学家之间的联合咨询,并补充了个人全科医生会议.
- 测量的主要结果是PHQ-9分数减少了50%,在基线和6,12和18个月时进行评估.
主要成果:
- 共有34名患者被录取,其中30人完成了后续评估.
- 虽然干预组表现出改善的趋势,但与对照组相比,PHQ-9分数下降50%的差异在统计学上并不显著.
- 这两组在18个月内均PHQ-9分数显著降低,但在任何时间点之间没有观察到统计学上显著的差异.
结论:
- 实施的结构化协作模型在治疗老年人抑郁症方面没有产生统计学上显著的积极结果.
- 在患者招募过程中遇到的重大挑战,导致参与率低,可能阻碍了该研究检测治疗效应的能力.
相关概念视频
Long-term Depression
33.1K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
33.1K
Long-term Depression
3.1K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
Calcium Ion Concentration Mechanism
If over...
3.1K
Pharmacodynamics in Geriatric Patients: Effects of Age
188
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
188
Depressive Disorders: MDD and Dysthymia
664
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
664
Drug Dosing: Geriatric Patients
227
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
227
Depression: Overview
794
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
794


